A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19
Clinical trial NCT04415073 · TERMINATED
Trial details
- NCT number
- NCT04415073
- Sponsor
- Syndax Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2020-07-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.